Tag: CV Sciences

ICR Announces Cannabis Track and Panels at 2019 ICR Conference

NEW YORK–(BUSINESS WIRE)–ICR, a leading strategic communications and advisory firm serving more than 650 private and public company clients, today announced its inaugural dedicated cannabis track at this year’s...
- January 9th, 2019 at 3:15 pm

American Cannabis Operators Decline 18.0% in December

Following a 5.8% decline in its inaugural month, the American Cannabis Operator Index fell 18.0% during December: During December, the index included 17 companies, including 12 multi-state operators (MSOs) and five focused...
- January 1st, 2019 at 8:35 am

13 Cannabis Stocks that Rallied in 2018

With just a single day of trading left in 2018, cannabis stocks, as measured by the Global Cannabis Stock Index, are on track to snap a two-year winning streak....
- December 29th, 2018 at 7:38 pm

CV Sciences Defends Stock After Short Seller Attacks

CV Sciences, Inc. provides corporate update to shareholders LAS VEGAS, Aug. 30, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) would like...
- August 30th, 2018 at 9:11 am

Global Cannabis Stocks Drop 10% in July

Cannabis stocks, as measured by the Global Cannabis Stock Index, fell again in July, declining 10.0% to 90.12 after posting a new 2018 low: The index, which had 53 qualifying members that...
- August 1st, 2018 at 12:34 pm

CBD Provider CV Sciences Applies to NASDAQ

CV Sciences, Inc. Files Application for Up-Listing to the NASDAQ Capital Market LAS VEGAS, July 23, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of...
- July 23rd, 2018 at 9:03 am

Global Cannabis Stocks Decline Almost 5% in June

Cannabis stocks, as measured by the Global Cannabis Stock Index, fell  again in June, declining 4.5% to 100.12, after going into the final week of the month with a small gain: The...
- July 1st, 2018 at 7:33 pm

CV Sciences Resolves SEC Litigation and Names New CEO

CV Sciences, Inc. Settles SEC Matter The Company Names New Chief Executive Officer, President and Board Member LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI)...
- June 1st, 2018 at 9:11 am

CV Sciences CBD Product Sales Jump 114% in Q1

CV Sciences, Inc. Reports First Quarter 2018 Financial Results – Record Quarter on All Key Financial Performance Metrics Including 114% Increase in Sales Year-Over-Year and Double Digit Sequential Sales...
- May 15th, 2018 at 11:24 am